- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
India targeting global arena with high value pharma med-tech products, says Mansukh Mandaviya
The minister urged the pharma and med-tech sectors to move out of their comfort zones and adopt innovation as a driving feature of their business strategies.
Davos: India is poised to take on the global arena and move from high-volume to high-value products in the pharma and med-tech sectors, Union Health Minister Mansukh Mandaviya said on Wednesday.
Addressing a roundtable discussion on opportunities in R&D and innovation in life sciences at the World Economic Forum here, the minister said the Government of India is committed to promoting Indian life sciences as a globally competitive sector to ensure the availability, accessibility, and affordability of drugs and medical devices in domestic and global markets.
"India is taking concerted and coordinated efforts on R&D and innovation in the pharma-medtech sector to indigenously develop cutting-edge products and technologies," he added.
Mandaviya said the union government is promoting an enabling ecosystem for innovation in the pharma-medtech sector to become a leader in drug discovery and innovative medical devices.
He said a large share of global value capture -- nearly 40 percent of a market of USD 6.65 trillion -- in the life sciences sector lies in innovation-based products.
Promoting drug discovery and innovation will unlock this value and also enhance the industry's contribution to the Indian economy, with additional USD 10-12 billion in exports every year, and create a large pool of jobs to enhance India's differentiation vis a vis other developing economies.
The increased spending on healthcare globally, the increase in the size of the Indian middle class, the commitment to universal healthcare and the attention to schemes such as Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (PM-JAY) and Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP) have created a sustained demand trajectory for pharma and med-tech sectors, he noted.
The demand for better therapeutic outcomes, trends in personalised diagnostics, in-home treatment, wearables, telemedicine etc have created scope for differentiated products and service offerings.
The minister urged the pharma and med-tech sectors to move out of their comfort zones and adopt innovation as a driving feature of their business strategies.
"India is now poised to take on the global arena and move from high-volume to high-value products," he said.
Mandaviya also said the government is strengthening the regulatory framework to facilitate innovation and research in product development. Indian regulators are now working towards establishing global harmonisation in this regard, with modifications in the regulatory provisions.
The government is also focussing on incentivising investments in innovation through a mix of fiscal and non-fiscal measures, thereby matching risks with remunerative financing options.
"We are looking at a range of interventions that would facilitate funding support for innovation such as schemes to support investments into R&D innovation, reimbursement of R&D spending and designing appropriate fiscal incentives to promote R&D," he stated.
Another focus area is creating a facilitatory ecosystem to support innovation and cross-sectoral research as a strong institutional mechanism for sustainable growth in the research and development and innovation sector, he said.
Mandaviya also highlighted efforts initiated by the government to integrate traditional medicines and phyto-pharmaceuticals into the mainstream public dialogue and practice.
The growth in this segment will have direct and indirect impact on employment, the farming community, industry, and academia, he added.
He also referred to the government support for the medical devices sector by a production-linked incentive (PLI) scheme and underlined that the bio-pharmaceuticals sector has delivered a 5-year Compound Annual Growth Rate (CAGR) of 50 per cent.
On Prime Minister Narendra Modi's call for 'Atmanirbhar Bharat' or 'self-reliant India', he said India can achieve self-reliance in pharmaceuticals and medical devices only by strengthening its R&D infrastructure that would drive the expansion of access to life-saving medicines and drugs and help the country become a global pharmaceuticals and medical devices exports hub.
pharmamedical technologyMansukh Mandaviyalife sciencesmedical devicesproduction linked incentive schemetraditional medicines
Source : PTIRuchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story